Combined treatment modality in small cell lung cancer: The impact of radiotherapy on survival

Strahlentherapie und Onkologie

Volumn 184, Issue 2, 2008, Pages 61-66

  Klautke, Gunther ^a   Sauer, Rolf ^b   Fietkau, Rainer ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Irradiation; Radiochemotherapy; Small cell lung cancer; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IRINOTECAN;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; ESOPHAGITIS; HUMAN; LUNG SMALL CELL CANCER; LUNG TOXICITY;

CARCINOMA, SMALL CELL; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; INCIDENCE; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 38949191602     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1839-x     Document Type: Editorial

References (46)

1. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:524-6.
2. Behneke R, Kriesen S, Klautke G, et al. Zeit- und volumenadaptierte Strahlentherapie beim kleinzelligen Bronchialkarzinom im Rahmen einer simultanen Radiochemotherapie. Strahlenther Onkol 2006;182:Suppl 1:30-1.
3. Berthelet E, Truong PT, Lesperance M, et al. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer. Am J Clin Oncol 2006;29:21-6.
4. Bese NS, Büyükünal E, Ozgüroglu M, et al. Toxicity and survival results of a phase II study investigating the role of postoperative chemoradioimmunotherapy for gastric adenocarcinoma. Strahlenther Onkol 2005;181:652-9.
5. Bischof M, Debus J, Herfarth K, et al. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Strahlenther Onkol 2007;183:679-84.
6. Bonner JA, Sloan JA, Shanahan TG, et al. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol 1999;17:2681-91.
7. Borst GR, De Jaeger K, Belderbos JS, et al. Pulmonary function changes after radiotherapy in non small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys 2005;62:639-44.
8. Bunn PA Jr, Lichter AS, Makuch RW, et al. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med 1987;106:655-62.
9. Chen M, Jiang Gl, Fu XL, et al. The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer 2000;28:11-9.
10. Choi NC, Herndon JE 2nd, Rosenman J, et al. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 1998;16:3528-36.
11. De Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited disease small-cell lung cancer. J Clin Oncol 2006;24:1057-63.
12. Diniz G, Unlu I, Gokce T, et al. Evaluation of curative and palliative radiotherapy efficacy in extensive stage small cell lung cancer. Saudi Med J 2006;27:992-6.
13. Fietkau R, Sauer R. Die frühzeitige Radiotherapie im Rahmen der Radiochemotherapie des kleinzelligen Bronchialkarzinoms ist im Stadium "Limited Disease" der späten Bestrahlung überlegen. Strahlenther Onkol 2002;178:585-8.
14. Fried DB, Morris DE, Poole C, et al. Systemic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004;22:4837-45.
15. Frytak S, Shaw EG, Jett JR, et al. Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer. Am J Clin Oncol 1996;19:193-8.
16. Gregor A, Drings P, Burghouts J, et al. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. J Clin Oncol 1997;15:2840-9.
17. Herrmann T, Baumann M. Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation. Strahlenther Onkol 2005;181:65-76.
18. Huncharek M, McGarry R. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer. Oncologist 2004;9:665-72.
19. Jeong HC, Lee SY, Lee SY, et al. Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease smallcell lung cancer. Lung Cancer 2006;53:361-6.
20. Jeremic B. Timing of concurrent radiotherapy and chemotherapy in limited-disease small-cell lung cancer: "meta-analysis of meta-analyses". Int J Radiat Oncol Biol Phys 2006;64:314-20.
21. Jeremic B, Shibamoto Y, Acimoviv L, et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 1997;15:893-900.
22. Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 1999;17:2092-9.
23. Klautke G, Fähndrich S, Semrau S, et al. Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I study. Lung Cancer 2006;53:183-8.
24. Kochhar R, Frytak S, Shaw EG. Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosis. Am J Clin Oncol 1997;20:125-7.
25. Kotalik J, Yu E, Markman BR, et al. Practice guideline on prophylactic cranial irradiation in small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001;50:309-16.
26. Lee JJ, Bekele BN, Zhou X, et al. Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 2006;24:3524-6.
27. Manapow F, Klautke G, Fietkau R. Wertigkeit des MRT des Neurokraniums vor einer prophylaktischen Ganzschädelbestrahlung bei Patienten mit SCLC, Limited Disease, in kompletter Remission. Strahlenther Onkol 2006;182:Sondernr 1:52.
28. Mehta MP. Models support prophylactic cranial irradiation. J Clin Oncol 2006;24:3524-6.
29. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993;11:336-44.
30. Niederle N, Eberhardt W, Hirche H. Pretherapeutic prognostic factors in small cell broncial cancer. Onkologie 1988;11:Suppl 2:34-40.
31. Nowara E, Suwinski R. Time factor in radiotherapy and chemotherapy for limited disease small-cell lung cancer. Cancer Invest 2007;25:163-71.
32. Paulsen F, Scheiderbauer J, Eschmann SM, et al. First experiences of radiation treatment planning with PET/CT. Strahlenther Onkol 2006;182:369-75.
33. Perry MC, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987;316:912-8.
34. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618-24.
35. Pijls-Johannesma MC, De Ruysscher D, Lambin P, et al. Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev 2005;25:CD004700.
36. Quan AL, Videtic GM, Suh JH. Brain metastases in small cell lung cancer. Oncology (Williston Park) 2004;18:961-72.
37. Schäfer C, Dietl B, Nelson K, et al. Short treatment time can be advantageous for patients with short survival time and arguments for compensating treatment gaps in palliative radiotherapy. Strahlenther Onkol 2005;181:615-6.
38. Shaw EG, Frytak S, Eagan RT, et al. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen of limited and extensive small-cell carcinoma of the lung. Am J Clin Oncol 1996;19:154-8.
39. Shaw EG, Su JQ, Eagan RT, et al. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data base. J Clin Oncol 1994;12:2327-32.
40. Skarlos DV, Samantas E, Briassoulis E, et al. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group. Ann Oncol 2001;12:1231-8.
41. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-72.
42. Spiro SG, James LE, Rudd RM, et al. Early compared with late radiotherapy in combined modality treatment for limited disease cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol 2006;24:3823-9.
43. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002;20:3045-7.
44. Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-71.
45. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;10:890-5.
46. Work E, Nielsen OS, Bentzen SM, et al. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. J Clin Oncol 1997;15:3030-7.